SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
GENEREX BIOTECHNOLOGY CORP
(NQPK:GNBT Last Sale: .0315 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQPK: (GNBT : $.0315)
$6 million Market Cap at September 12, 2013
Employs 21.
Biomedics SubIndustry up .00% / Health Industry up .00% Today

33 Harbour Square Research Report Earnings Snapshot - Last 03/11/17
Suite 202 Fact Sheet
Toronto, Ontario, Financial Statements
Canada Peer Comparison
Phone: (416) 364-2551 Annual Reports

Anna E. Gluskin, Chmn./CEO, Rose C. Perri, COO/CFO
Transfer to Pink Sheets October 20, 2010. Makes Oral-lyn, an insulin spray formulation used for the treatment of Type-1 and Type-2 diabetes. Drug delivery systems, administered as a fine spray into the mouth using Rapidmist.
Historical Charts    Technical Analysis
No Historical Data available for GNBT

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common GNBT $.0315 $ 0 $.03 $.032 1,583,037 $.02 $.085 183,617
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $5,784

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
11-NOV-99 GNBTE Symbol Changed to GNBT
04-NOV-99 GNBT Symbol Changed to GNBTE
11-JUN-99 GNBTD Symbol Changed to GNBT
03-MAY-99 GNBT Symbol Changed to GNBTD

A6
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex